Phio Pharmaceuticals Corp. (NASDAQ:click here).
Li Auto Posts 23.4% Growth In January Deliveries
Li Auto Inc (NASDAQ:LI) said it delivered 15,141 vehicles in January 2023, a 23.4% increase year-on-year. The cumulative deliveries of Li…
Phio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor Control
Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today
Related Posts
Citigroup Reinstates Buy on Lucid Gr, Announces $28 Price Target
Citigroup analyst Itay Michaeli reinstates Lucid Gr (NASDAQ:LCID) with a Buy and announces $28 price target.
Medtronic Affera Mapping And Ablation System With Sphere-9 Catheter Achieves Endpoints For Safety And Efficacy
The Sphere-9 Catheter demonstrated a positive safety profile with an excellent primary safety endpoint rate of 1.4% (1.0% for the control arm). Importantly, no safety events including pulmonary vein stenosis, esophageal
What’s Going On With Sidus Space Stock Today?
Sidus Space Inc (NASDAQ: SIDU) shares are trading higher Tuesday after the company announced it was awarded an additional Bechtel cable assembly contract